Learn About Pediatric Myocarditis

What is the definition of Pediatric Myocarditis?

Pediatric myocarditis is inflammation of the heart muscle in an infant or young child.

Save information for later
Sign Up
What are the causes of Pediatric Myocarditis?

Myocarditis is rare in young children. It is slightly more common in older children and adults. It is often worse in newborns and young infants than in children over age 2.

Most cases in children are caused by a virus that reaches the heart. These can include:

  • Influenza (flu) virus
  • Coxsackie virus
  • Parovirus
  • Adenovirus
  • SARS-CoV-2 virus (the virus that causes COVID-19)

It may also be caused by bacterial infections such as Lyme disease.

Other causes of pediatric myocarditis include:

  • Allergic reactions to certain medicines
  • Exposure to chemicals in the environment
  • Infections due to fungus or parasites
  • Radiation
  • Some diseases (autoimmune disorders) that cause inflammation throughout the body
  • Some drugs

Myocarditis following COVID-19 vaccination has been reported, but is very rare.

The heart muscle may be directly damaged by the virus or the bacteria that infect it. The body's immune response can also damage the heart muscle (called the myocardium) in the process of fighting the infection. This can lead to symptoms of heart failure.

What are the symptoms of Pediatric Myocarditis?

Symptoms may be mild at first and hard to detect. Sometimes in newborns and infants, symptoms may appear suddenly.

Symptoms may include:

  • Anxiousness
  • Failure to thrive or poor weight gain
  • Feeding difficulties
  • Fever and other symptoms of infection
  • Listlessness
  • Low urine output (a sign of decreasing kidney function)
  • Pale, cool hands and feet (a sign of poor circulation)
  • Rapid breathing
  • Rapid heart rate

Symptoms in children over age 2 may also include:

  • Belly area pain and nausea
  • Chest pain
  • Cough
  • Fatigue
  • Shortness of breath
  • Swelling (edema) in the legs, feet, and face
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Pediatric Myocarditis?

There is no cure for myocarditis. The heart muscle inflammation will often go away on its own.

The goal of treatment is to support heart function until the inflammation goes away. Many children with this condition are admitted to a hospital. Activity often needs to be limited while the heart is inflamed because it can strain the heart.

Treatment may include:

  • Antibiotics to fight bacterial infection
  • Anti-inflammatory medicines called steroids to control inflammation
  • Intravenous immunoglobulin (IVIG), a medicine made of substances (called antibodies) that the body produces to fight infection, to control the inflammatory process
  • Mechanical support using a machine to help the heart function (in extreme cases)
  • Medicines to treat symptoms of heart failure
  • Medicines to treat abnormal heart rhythms
Who are the top Pediatric Myocarditis Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What is the outlook (prognosis) for Pediatric Myocarditis?

Recovery from myocarditis depends on the cause of the problem and the child's overall health. Most children recover completely with proper treatment. However, some may have permanent heart disease.

Newborns have the highest risk for serious disease and complications (including death) due to myocarditis. In rare cases, severe damage to the heart muscle requires a heart transplant.

What are the possible complications of Pediatric Myocarditis?

Complications may include:

  • Enlargement of the heart that leads to reduced heart function (dilated cardiomyopathy)
  • Heart failure
  • Heart rhythm problems
When should I contact a medical professional for Pediatric Myocarditis?

Contact your child's pediatrician if signs or symptoms of this condition occur.

How do I prevent Pediatric Myocarditis?

There is no known prevention. However, prompt testing and treatment may reduce the disease risk.

Myocarditis
What are the latest Pediatric Myocarditis Clinical Trials?
European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID Patients in ECMO

Summary: In the last 10 years, severe acute respiratory infection (SARI) was responsible of multiple outbreaks putting a strain on the public health worldwide. Indeed, SARI had a relevant role in the development of pandemic and epidemic with terrible consequences such as the 2009 H1N1 pandemic which led to more than 200.000 respiratory deaths globally. In late December 2019, in Wuhan, Hubei, China, a new r...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Population-based Incidence of Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Danish Children 5-11 Years Old

Summary: Myopericarditis is a rare complication to messenger ribonucleic acid (mRNA) COVID-19 vaccines, especially in male adolescents and young adults. The risk in children 5-11 years old is unknown. In Denmark, the Pfizer-BioNTech mRNA COVID-19 vaccination was recommended from December 1, 2021 in individuals aged 5-11 years old. We aim to estimate the incidence of myopericarditis in children 5-11 years o...

What are the Latest Advances for Pediatric Myocarditis?
Clinical Efficacy of Creatine Phosphate Sodium and/or Vitamin C in the Treatment of Children with Viral Myocarditis: A Meta-Analysis.
Neonatal MIS-C: Managing the Cytokine Storm.
Tired of the same old research?
Check Latest Advances
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.
Who are the sources who wrote this article ?

Published Date: February 24, 2022
Published By: Neil K. Kaneshiro, MD, MHA, Clinical Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 08/24/2022.

What are the references for this article ?

Centers for Disease Control and Prevention. Safety of COVID-19 vaccines. www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html. Updated August 22, 2022. Accessed August 24, 2022.

Knowlton KU, Anderson JL, Savoia MC, Oxman MN. Myocarditis and pericarditis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 84.

McNamara DM. Heart failure as a consequence of viral and nonviral myocarditis. In: Felker GM, Mann DL, eds. Heart Failure: A Companion to Braunwald's Heart Disease. 4th ed. Philadelphia, PA: Elsevier; 2020:chap 28.

Parent JJ, Ware SM. Diseases of the myocardium. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 466.